Early use of autogenous arteriovenous fistula in patients with urgent hemodialysis.

Int Urol Nephrol

Department of Nephrology, Qianfoshan Hospital, Shandong University, No. 16766. Jingshi Road, Jinan, 250011, Shandong, China.

Published: June 2017

Purpose: This study was designed to evaluate the long-term patency rate and complications associated with early use of the autogenous forearm arteriovenous fistula (AFAVF) in patients needing urgent hemodialysis.

Methods: The clinical data of all patients undergoing AFAVFs for hemodialysis access between June 1996 and June 2016 were retrospectively evaluated. The primary and secondary patencies were estimated using the life table method.

Results: A total of 104 AFAVFs were created for 102 patients. All patients had entered hemodialysis when fistulas were constructed. The mean time to the first cannulation of the AFAVF was 17.33 ± 4.60 (5-27 days). Four AFAVFs (3.8%) became occluded within 30 days of creation of the access, and five AFAVFs (4.8%) had hematomas after cannulation. There were no cases of infection of the wound or steal syndrome or prolonged arm edema. The primary patency rate was 77.81% at 1 year, 73.05% at 2 years, 64.64% at 3 years, 60.75% at 5 years and 47.48% at 10 years. The secondary patency rate was 96.78% at 1 year, 95.18% at 5 years and 85.81% at 10 years.

Conclusions: In this study, the patency rates following the early use of the AFAVFs were not inferior to the previously reported patency rates in the literature. For patients entering hemodialysis with an inserted central catheter, the early use of the AFAVFs decreases the complications associated with catheters.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11255-017-1557-3DOI Listing

Publication Analysis

Top Keywords

patency rate
12
early autogenous
8
arteriovenous fistula
8
complications associated
8
patency rates
8
early afavfs
8
patients
6
afavfs
6
patency
5
early
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!